Estimation of iron overload with T2*MRI in children treated for hematological malignancies

References

• Watkins T, Surowiecka MK, McCullough J. Transfusion indications for patients with cancer. Cancer Control. 2015;22(1):38–46. doi:10.1177/107327481502200106.
   PubMed Web of Science ®Google Scholar
• Nottage K, Gurney JG, Smeltzer M, Castellanos M, Hudson MM, Hankins JS. Trends in transfusion burden among long-term survivors of childhood hematological malignancies. Leuk Lymphoma. 2013;54(8):1719–1723. doi:10.3109/10428194.2012.750724.
   PubMed Web of Science ®Google Scholar
• Telfer PT, Prestcott E, Holden S, Walker M, Hoffbrand AV, Wonke B. Hepatic iron concentration combined with long-term monitoring of serum ferritin to predict complications of iron overload in thalassaemia major. Br J Haematol. 2000;110(4):971–977. doi:10.1046/j.1365-2141.2000.02298.x.
   PubMed Web of Science ®Google Scholar
• Wood JC. Magnetic resonance imaging measurement of iron overload. Curr Opi Hematol. 2007;14:183–190.
   PubMed Web of Science ®Google Scholar
• Kirk P, He T, Anderson LJ, et al. International reproducibility of single breathhold T2*MR for cardiac and liver iron assessment among five thalassemia centers. J Magn Reson Imag. 2010;32(2):315–319. doi:10.1002/jmri.22245.
   PubMed Web of Science ®Google Scholar
• Vora A, Goulden N, Wade R, et al. Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial. Lancet Oncol. 2013;14(3):199–209. doi:10.1016/S1470-2045(12)70600-9.
   PubMed Web of Science ®Google Scholar
• Burnett AK, Russell NH, Hills RK, et al. Optimization of chemotherapy for younger patients with acute myeloid leukemia: results of the medical research council AML15 trial. JCO. 2013;31(27):3360–3368. doi:10.1200/JCO.2012.47.4874.
   PubMed Web of Science ®Google Scholar
• Mandal S, Sodhi KS, Bansal D, et al. MRI for quantification of liver and cardiac iron in thalassemia major patients: pilot study in Indian population. Indian J Pediatr. 2017;84(4):276–282. doi:10.1007/s12098-017-2310-8.
   PubMed Web of Science ®Google Scholar
• Hankins JS, McCarville MB, Loeffler RB, et al. R2*magnetic resonance imaging of the liver in patients with iron overload. Blood. 2009;113(20):4853–4855. doi:10.1182/blood-2008-12-191643.
   PubMed Web of Science ®Google Scholar
• Carpenter JP, He T, Kirk P, et al. On T2*magnetic resonance and cardiac iron. Circulation. 2011;123(14):1519–1528. doi:10.1161/CIRCULATIONAHA.110.007641.
   PubMed Web of Science ®Google Scholar
• Shenoy N, Vallumsetla N, Rachmilewitz E, Verma A, Ginzburg Y. Impact of iron overload and potential benefit from iron chelation in low-risk myelodysplastic syndrome. Blood. 2014;124(6):873–881. doi:10.1182/blood-2014-03-563221.
   PubMed Web of Science ®Google Scholar
• Papanikolaou G, Pantopoulos K. Iron metabolism and toxicity. Toxicol Appl Pharmacol. 2005;202(2):199–211. doi:10.1016/j.taap.2004.06.021.
   PubMed Web of Science ®Google Scholar
• Cappellini MD, Cohen A, Porter J, Taher A, Viprakasit V. Guidelines for the Management of Transfusion Dependent Thalassaemia (TDT). 3rd ed. Nicosia, Cyprus: Thalassaemia International Federation; 2014.
   Google Scholar
• Weinberg ED. The hazards of iron loading. Metallomics. 2010;2(11):732–740. doi:10.1039/c0mt00023j.
   PubMed Web of Science ®Google Scholar
• Hartmann J, Braulke F, Sinzig U, et al. Iron overload impairs proliferation of erythroid progenitors cells (BFU-E) from patients with myelodysplastic syndromes. Leuk Res. 2013;37(3):327–332. doi:10.1016/j.leukres.2012.11.005.
   PubMed Web of Science ®Google Scholar
• Weinberg ED. Iron withholding: a defense against viral infections. Biometals. 1996;9(4):393–399. doi:10.1007/BF00140609.
   PubMedGoogle Scholar
• Weinberg ED. Iron in neoplastic disease. Nutr Cancer. 1983;4(3):223–233. doi:10.1080/01635588209513761.
   PubMedGoogle Scholar
• Koreth J, Antin JH. Iron overload in hematologic malignancies and outcome of allogeneic hematopoietic stem cell transplantation. Haematologica. 2010;95(3):364–366. doi:10.3324/haematol.2009.017244.
   PubMedGoogle Scholar
• Barton JC, Bertoli LF. Transfusion iron overload in adults with acute leukemia: manifestations and therapy. Am J Med Sci. 2000;319(2):73–78. doi:10.1097/00000441-200002000-00001.
   PubMedGoogle Scholar
• Halonen P, Mattila J, Suominen P, Ruuska T, Salo MK, Mäkipernaa A. Iron overload in children who are treated for acute lymphoblastic leukemia estimated by liver siderosis and serum iron parameters. Pediatrics. 2003;111(1):91–96. doi:10.1542/peds.111.1.91.
   PubMed Web of Science ®Google Scholar
• Olcay L, Hazirolan T, Yildirmak Y, et al. Biochemical, radiologic, ultrastructural, and genetic evaluation of iron overload in acute leukemia and iron-chelation therapy. J Pediatr Hematol Oncol. 2014;36(4):281–292. doi:10.1097/MPH.0b013e3182a11698.
   PubMedGoogle Scholar
• Nair M, Kuttath V, Nair AR, et al. Iron overload in children with leukemia receiving multiple blood transfusions. Indian Pediatr. 2018;55(11):962–965. doi:10.1007/s13312-018-1418-x.
   PubMedGoogle Scholar
• Au WY, Lam WM, Chu WC, et al. A magnetic resonance imaging study of iron overload in hemopoietic stem cell transplant recipients with increased ferritin levels. Transplant Proc. 2007;39(10):3369–3374. doi:10.1016/j.transproceed.2007.09.027.
   PubMedGoogle Scholar
• Vag T, Kentouche K, Krumbein I, et al. Noninvasive measurement of liver iron concentration at MRI in children with acute leukemia: initial results. Pediatr Radiol. 2011;41(8):980–984. doi:10.1007/s00247-011-2122-3.
   PubMedGoogle Scholar
• Unal S, Cetin M, Hazirolan T, et al. Number of erythrocyte transfusions is more predictive than serum ferritin in estimation of cardiac iron loading in pediatric patients with acute lymphoblastic leukemia. Leuk Res. 2014;38(8):882–885. doi:10.1016/j.leukres.2014.05.002.
   PubMed Web of Science ®Google Scholar
• Chirico V, Rigoli L, Lacquaniti A, et al. Endocrinopathies, metabolic disorders, and iron overload in major and intermedia thalassemia: serum ferritin as diagnostic and predictive marker associated with liver and cardiac T2*MRI assessment. Eur J Haematol. 2015;94(5):404–412. doi:10.1111/ejh.12444.
   PubMed Web of Science ®Google Scholar
• Schempp A, Lee J, Kearney S, Mulrooney DA, Smith AR. Iron overload in survivors of childhood cancer. J Pediatr Hematol Oncol. 2016;38(1):27–31. doi:10.1097/MPH.0000000000000444.
   PubMed Web of Science ®Google Scholar
• de Ville de Goyet M, Moniotte S, Robert A, et al. Iron overload in children undergoing cancer treatments. Pediatr Blood Cancer. 2013;60(12):1982–1987. doi:10.1002/pbc.24705.
   PubMed Web of Science ®Google Scholar
• Ruccione KS, Wood JC, Sposto R, Malvar J, Chen C, Freyer DR. Characterization of transfusion-derived iron deposition in childhood cancer survivors. Cancer Epidemiol Biomark. 2014;23(9):1913–1919. doi:10.1158/1055-9965.EPI-14-0292.
   PubMedGoogle Scholar
• Armand P, Kim HT, Rhodes J, et al. Iron overload in patients with acute leukemia or MDS undergoing myeloablative stem cell transplantation. Biol Blood Marrow Transplant. 2011;17(6):852–860. doi:10.1016/j.bbmt.2010.09.006.
   PubMed Web of Science ®Google Scholar
• Rascon J, Rageliene L, Stankeviciene S, et al. An assessment of iron overload in children treated for cancer and nonmalignant hematologic disorders. Eur J Pediatr. 2014;173(9):1137–1146. doi:10.1007/s00431-014-2295-5.
   PubMedGoogle Scholar
• Acar S, Gözmen S, Bayraktaroglu S, et al. Evaluation of liver iron content by magnetic resonance imaging in children with acute lymphoblastic leukemia after cessation of treatment. TJH. 2020;37(4):263–270. doi:10.4274/tjh.galenos.2020.2019.0364.
   Google Scholar
• Sait S, Zaghloul N, Patel A, Shah T, Iacobas I, Calderwood S. Transfusion related iron overload in pediatric oncology patients treated at a tertiary care centre and treatment with chelation therapy. Pediatr Blood Cancer. 2014;61(12):2319–2320. doi:10.1002/pbc.25189.
   PubMedGoogle Scholar
• Sirvent A, Auquier P, Oudin C, et al. Prevalence and risk factors of iron overload after hematopoietic stem cell transplantation for childhood acute leukemia: a LEA study. Bone Marrow Transplant. 2017;52(1):80–87. doi:10.1038/bmt.2016.205.
   PubMed Web of Science ®Google Scholar
• Ktena YP, Athanasiadou A, Lambrou G, Adamaki M, Moschovi M. Iron chelation with deferasirox for the treatment of secondary hemosiderosis in pediatric oncology patients: a single-center experience. J Pediatr Hematol Oncol. 2013;35(6):447–450. doi:10.1097/MPH.0b013e318292baf5.
   PubMedGoogle Scholar
• Andrés-Jensen L, Skipper MT, Mielke Christensen K, Hedegaard Johnsen P, Aagaard Myhr K, et al. National, clinical cohort study of late effects among survivors of acute lymphoblastic leukaemia: the ALL-STAR study protocol. BMJ Open. 2021;11(2):e045543. doi:10.1136/bmjopen-2020-045543.
   PubMedGoogle Scholar